Mood stabilizers

BioXcel Therapeutics Announces Presentations at the ISBD 2021 Global Annual Conference

Retrieved on: 
Tuesday, May 11, 2021
Psychiatry, Receptor antagonists, Abnormal psychology, Psychiatric diagnosis, Atypical antipsychotics, Mood stabilizers, Psychopathology, Bipolar disorder, Depression, Agitation, Schizophrenia, Dementia

BXCL501 has been granted Breakthrough Therapy designation for the acute treatment of agitation associated with dementia and Fast Track designation for the acute treatment of agitation associated with schizophrenia, bipolar disorders and dementia.

Key Points: 
  • BXCL501 has been granted Breakthrough Therapy designation for the acute treatment of agitation associated with dementia and Fast Track designation for the acute treatment of agitation associated with schizophrenia, bipolar disorders and dementia.
  • The Company recently submitted its New Drug Application to the FDA for BXCL501 for the acute treatment of agitation associated with schizophrenia and bipolar disorders.
  • The safety and efficacy of BXCL501 has not been established.\nBioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology.
  • BioXcel\xe2\x80\x99s drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices.

Origen Acquires Additional Lithium Claims in Newfoundland

Retrieved on: 
Thursday, April 29, 2021
Physical sciences, Chemistry, Natural sciences, Lithium, Mood stabilizers, Pegmatite

b'Vancouver, British Columbia--(Newsfile Corp. - April 29, 2021) - Origen Resources Inc. (CSE: ORGN) (FSE: 4VX) (the "Company" or "Origen") is pleased to announce that it has acquired two additional claim blocks covering 4,600 hectares within the Newfoundland Lithium Belt.

Key Points: 
  • b'Vancouver, British Columbia--(Newsfile Corp. - April 29, 2021) - Origen Resources Inc. (CSE: ORGN) (FSE: 4VX) (the "Company" or "Origen") is pleased to announce that it has acquired two additional claim blocks covering 4,600 hectares within the Newfoundland Lithium Belt.
  • The immediate goal is to further define our target areas in this new prospective lithium belt by applying exploration techniques developed over the last two decades on the Avalonia (Leinster) pegmatite belt in Ireland.
  • The Company will apply experience from Ireland and North America in district-scale pegmatite zoning to focus these efforts.\nThe Newfoundland Lithium Belt exhibits all the characteristics of a major lithium rich corridor as observed in Ireland and the Carolinas.
  • There are key indicative signs that point to specific target areas with high expectations for the discovery of lithium rich pegmatites.

Lithium South Development Corporation: Drill Program to Expand Resource

Retrieved on: 
Tuesday, April 27, 2021
Chemistry, Physical sciences, Natural sciences, Alkali metals, Chemical elements, Reducing agents, Lithium compounds, Mood stabilizers, Lithium, Potassium

The current resource of 571,000 tonnes of lithium carbonate equivalent is located on the 383-hectare Tramo Claim.

Key Points: 
  • The current resource of 571,000 tonnes of lithium carbonate equivalent is located on the 383-hectare Tramo Claim.
  • Cutoff grade: 500 mg/L lithium, but no laboratory results were less than the cutoff grade.
  • The equations are Li x 5.3228 = lithium carbonate equivalent and K x 1.907 = potassium chloride equivalent.
  • The Company has located a service provider who has a drill rig located on the salar near the Alba Sabrina claim block and is negotiating a drill contract.

Lithium South Development Corporation: Drill Program to Expand Resource

Retrieved on: 
Tuesday, April 27, 2021
Chemistry, Physical sciences, Natural sciences, Alkali metals, Chemical elements, Reducing agents, Lithium compounds, Mood stabilizers, Lithium, Potassium

The current resource of 571,000 tonnes of lithium carbonate equivalent is located on the 383-hectare Tramo Claim.

Key Points: 
  • The current resource of 571,000 tonnes of lithium carbonate equivalent is located on the 383-hectare Tramo Claim.
  • Cutoff grade: 500 mg/L lithium, but no laboratory results were less than the cutoff grade.
  • The equations are Li x 5.3228 = lithium carbonate equivalent and K x 1.907 = potassium chloride equivalent.
  • The Company has located a service provider who has a drill rig located on the salar near the Alba Sabrina claim block and is negotiating a drill contract.

Emerging Markets Report: Salad Days Ahead for Lithium

Retrieved on: 
Monday, April 26, 2021
Chemistry, Physical sciences, Natural sciences, Lithium, Mood stabilizers

b'ORLANDO, Fla., April 26, 2021 (GLOBE NEWSWIRE) -- While doing our usual research for Lithium South Development Corporation (TSX-V: LIS) (OTCQB: LISMF) (Frankfurt OGPQ) a recent article from Forbes really stood out amid the various other commentaries and reporting.\nIf you\xe2\x80\x99re a fan of lithium companies like Lithium South Development Corp or the lithium industry, it\xe2\x80\x99s a must read in full at this link .\nShort of that, let\xe2\x80\x99s take a succinct look at how the author arrives at the conclusion that lithium is headed for very good times or \xe2\x80\x98salad days\xe2\x80\x99 as he calls them.\nHere are a few critical excerpts:\nLithium demand is expected to more than double by 2024.\nEurope now uses more lithium to power vehicles than diesel and gasoline may not be far behind.\nWhile lithium deposits are found around the world and lithium is elementally found in sea water, few deposits are feasible to explore and develop profitably.\nLithium has the potential to become the new oil.\nIf every EV company took their 2023 plans and went to the lithium market today, they\xe2\x80\x99d probably only get about 15% of their needed supply of lithium.\nThose are staggering comments and predictions and time will tell.

Key Points: 
  • b'ORLANDO, Fla., April 26, 2021 (GLOBE NEWSWIRE) -- While doing our usual research for Lithium South Development Corporation (TSX-V: LIS) (OTCQB: LISMF) (Frankfurt OGPQ) a recent article from Forbes really stood out amid the various other commentaries and reporting.\nIf you\xe2\x80\x99re a fan of lithium companies like Lithium South Development Corp or the lithium industry, it\xe2\x80\x99s a must read in full at this link .\nShort of that, let\xe2\x80\x99s take a succinct look at how the author arrives at the conclusion that lithium is headed for very good times or \xe2\x80\x98salad days\xe2\x80\x99 as he calls them.\nHere are a few critical excerpts:\nLithium demand is expected to more than double by 2024.\nEurope now uses more lithium to power vehicles than diesel and gasoline may not be far behind.\nWhile lithium deposits are found around the world and lithium is elementally found in sea water, few deposits are feasible to explore and develop profitably.\nLithium has the potential to become the new oil.\nIf every EV company took their 2023 plans and went to the lithium market today, they\xe2\x80\x99d probably only get about 15% of their needed supply of lithium.\nThose are staggering comments and predictions and time will tell.
  • But it is inarguable that the need for lithium is increasing at an accelerated rate and that Companies like Lithium South Development Corp. which controls its own destiny through its lithium mining operations could find it well positioned and enjoying its own salad days.\nAbout The Emerging Markets Report:\nThe Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience.
  • Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.\nFor more informative reports such as this, please sign up at http://www.emergingmarketsllc.com/newsletter.php\n'

Delpor Announces First Patient Dosed in Phase 1b/2a Clinical Trial of Once-Yearly Risperidone Implant

Retrieved on: 
Thursday, April 22, 2021
Biotechnology, Mental health, Health, Pharmaceutical, Clinical trials, Psychiatry, Chemical compounds, Psychopathology, Atypical antipsychotics, Abnormal psychology, Mood stabilizers, Piperidines, Lactams, Risperidone, Antipsychotic, Schizophrenia, Psychosis, Delpor, DLP-114, DELPOR, DLP-114

b'Delpor, Inc. (Delpor), a clinical stage biopharmaceutical company that utilizes innovative technologies in order to develop once-yearly therapies for chronic conditions, today announced that it has initiated and dosed the first patient in a phase 1b/2a clinical trial of DLP-114, a long-acting formulation of the antipsychotic risperidone for schizophrenia maintenance therapy.

Key Points: 
  • b'Delpor, Inc. (Delpor), a clinical stage biopharmaceutical company that utilizes innovative technologies in order to develop once-yearly therapies for chronic conditions, today announced that it has initiated and dosed the first patient in a phase 1b/2a clinical trial of DLP-114, a long-acting formulation of the antipsychotic risperidone for schizophrenia maintenance therapy.
  • This is an open-label study in stable schizophrenia patients to evaluate the safety, tolerability, and pharmacokinetics of switching from oral risperidone to a once-yearly or twice-yearly risperidone implant (DLP-114).\nThis press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20210422005028/en/\n\xe2\x80\x9cThe dosing of the first patient in our Phase 1b/2a clinical trial is an important milestone for Delpor and our lead asset, DLP-114,\xe2\x80\x9d said Tassos Nicolaou, Delpor\xe2\x80\x99s President and Chief Executive Officer.
  • Delpor is also pursuing 6-12-month formulations of other drugs targeting CNS conditions including Schizophrenia, Addiction, Spasticity, Parkinson\xe2\x80\x99s, Alzheimer\xe2\x80\x99s, and other conditions.

Lilac Solutions Achieves 99% Lithium Recovery With Ion Exchange Process

Retrieved on: 
Tuesday, April 13, 2021
Chemistry, Physical sciences, Natural sciences, Mood stabilizers, Lithium compounds, Salts, Lithium, Carbonates, Lithium carbonate, Brine, Reverse osmosis, Lithium-ion battery

The results produced a lithium chloride eluate solution recovering 99% of the lithium with very low reagent consumption.

Key Points: 
  • The results produced a lithium chloride eluate solution recovering 99% of the lithium with very low reagent consumption.
  • This eluate would be concentrated using reverse osmosis and mechanical evaporation to feed a conventional plant for the production of lithium hydroxide or lithium carbonate.
  • Lilac\'s new lithium extraction process enables rapid and low cost extraction of lithium from brine with minimal water and energy.
  • It provides lithium developers an alternative to conventional extraction methods utilizing its patented Ion Exchange IX media.

Lilac Solutions Achieves 99% Lithium Recovery With Ion Exchange Process

Retrieved on: 
Tuesday, April 13, 2021
Chemistry, Physical sciences, Natural sciences, Mood stabilizers, Lithium compounds, Salts, Lithium, Carbonates, Lithium carbonate, Brine, Reverse osmosis, Lithium-ion battery

The results produced a lithium chloride eluate solution recovering 99% of the lithium with very low reagent consumption.

Key Points: 
  • The results produced a lithium chloride eluate solution recovering 99% of the lithium with very low reagent consumption.
  • This eluate would be concentrated using reverse osmosis and mechanical evaporation to feed a conventional plant for the production of lithium hydroxide or lithium carbonate.
  • Lilac\'s new lithium extraction process enables rapid and low cost extraction of lithium from brine with minimal water and energy.
  • It provides lithium developers an alternative to conventional extraction methods utilizing its patented Ion Exchange IX media.

Bulk Brine Sample for Direct Lithium Extraction Test Work

Retrieved on: 
Thursday, April 8, 2021
Chemistry, Physical sciences, Chemical elements, Natural sciences, Lithium, Mood stabilizers, Helium

A 6,000-liter sample will be obtained for shipment to China, and North America for Direct Lithium Extraction test work.

Key Points: 
  • A 6,000-liter sample will be obtained for shipment to China, and North America for Direct Lithium Extraction test work.
  • A 2,000-liter bulk brine sample will be received in Chengdu China, by Chemphys for further testing of their XFP DLE process.
  • The remainder of the sample will be used for test work in Salta, Argentina and North America, further details to be provided.
  • The Company is focused on evaluating alternative extraction methods for the HMN Li Project and plans to become a leader in the application of Direct Lithium Extraction technology at the project level.

Bulk Brine Sample for Direct Lithium Extraction Test Work

Retrieved on: 
Thursday, April 8, 2021
Chemistry, Physical sciences, Chemical elements, Natural sciences, Lithium, Mood stabilizers, Helium

A 6,000-liter sample will be obtained for shipment to China, and North America for Direct Lithium Extraction test work.

Key Points: 
  • A 6,000-liter sample will be obtained for shipment to China, and North America for Direct Lithium Extraction test work.
  • A 2,000-liter bulk brine sample will be received in Chengdu China, by Chemphys for further testing of their XFP DLE process.
  • The remainder of the sample will be used for test work in Salta, Argentina and North America, further details to be provided.
  • The Company is focused on evaluating alternative extraction methods for the HMN Li Project and plans to become a leader in the application of Direct Lithium Extraction technology at the project level.